The Motley Fool Discussion Boards

Previous Page

Stocks C / CNS, Inc.


Subject:  Epitaph for CNS Date:  12/20/2006  5:45 PM
Author:  EyesGlazed Number:  129 of 132

This buyout was very good for us shareholders. I made 60% on CNS (thanks Motley Fool!) and I'm sure others did even better. But as is often the case, the acquisition wasn't so hot for employees. Here's an excerpt from yesterday's news coverage of the closing:

"GSK spokesman Brian Jones said Tuesday that the company intends to move CNS' operations out of Minnesota. CNS' commercial operations will be shifted to an existing GSK facility in Pittsburgh, and research and development operations will be shifted to Parsippany, N.J., Jones said.

GSK offered positions to 10 of CNS' 60 employees, Jones said. The remaining 50 were laid off."

That sucks! This is what happens to a good company: it gets devoured and broken up, and its employees get canned. Sorry to be a downer, but I thought the outcome for CNS' people was worth noting.


Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us